Isaac Bogoch
Dr. Isaac Bogoch, MD, SM is a Canadian infectious diseases specialist based in Toronto, Ontario.
Education
Bogoch completed medical school and Internal Medicine residency training at the University of Toronto, and then specialized in Infectious Diseases at Harvard University. He holds a Masters Degree in Clinical Epidemiology from the Harvard T.H. Chan School of Public Health, and has completed fellowships in both Tropical Infectious Diseases and HIV care.
Career and Affiliations
Bogoch has been a presenter at events for the British Columbia Pharmacy Association (BCPhA).1)
University of Toronto
Bogoch is an associate professor in the Department of Medicine at the University of Toronto.2) 3)
Toronto General Hospital
Bogoch is an infectious diseases consultant at Toronto General Hospital under the University Health Network with a focus on tropical diseases, HIV, and general infectious diseases.4)
Ontario COVID-19 Science Advisory Table
Bogoch is a member of the Modelling Consensus Table of the Ontario COVID-19 Science Advisory Table.5)
Ontario COVID-19 Vaccine Distribution Task Force
Bogoch was a member of the Ontario COVID-19 Vaccine Distribution Task Force under the Solicitor General of Ontario and the Ontario Minister of Health.6) 7) His term was December 4, 2020 to August 31, 2021.
Consulting
Bogoch was hired by the NHL Players' Association to review their COVID-19 safety protocols.8) 9)
He also received consulting fees from BlueDot, the Canadian artificial intelligence company that claimed responsibility for being first in the world to detect the initial spread of SARS-CoV-2 in Wuhan, China in December 2020. Indeed, Bogoch is the lead author on a study titled “Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel” with the BlueDot team.10) The study was submitted to the Journal of Travel Medicine on January 8, revised January 9, and accepted January 10, 2020.
Research
Zika
In 2016, Bogoch published a paper on the Zika virus funded by the Canadian Institutes of Health Research (CIHR), National Institutes of Health (NIH), Wellcome Trust, Bill & Melinda Gates Foundation, and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Fogarty International Center. RAPIDD is co-funded by the Science & Technology Directorate of the U.S. Department of Homeland Security.11)
COVID-19
Bogoch received grant funding from the Canadian Institutes of Health Research (CIHR) to “study the global spread of COVID-19”.12) 13)
One such grant was awarded on February 1, 2020.14) The program called on applicants to:
- “Contribute to the global response to the 2019-nCoV outbreak;
- Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
- Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
- Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.”